Coloplast AS (COLO B):企業の財務・戦略的SWOT分析

◆英語タイトル:Coloplast AS (COLO B) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME529FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年2月
◆ページ数:56
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:デンマーク
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Coloplast AS (COLO B) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Coloplast A/S (Coloplast) manufactures and sells products and offers services for ostomy care, urology care, continence care, and skin and wound care. Its major products include urisheaths; ostomy bags; urine bags; catheters; anal irrigation systems; sling products; advanced foam dressings and hydrocolloid dressings for protection of skin and pressure injuries; cleansers; moisturizers; skin protectants; anti-fungals; and hand cleansers. The company offers its products under brands including SenSura, SpeediCath, Persiteen, Biatain, Conveen, InterDry, Brava and Comfeel. Coloplast supplies its products through subsidiaries and distributors to hospitals, institutions, wholesalers and retailers in Europe, Africa, South America, Asia, Russia, Australia and North America. Coloplast is headquartered in Humlebaek, Denmark.

Coloplast AS Key Recent Developments

Nov 04,2020: Coloplast acquires tibial nerve stimulation developer Nine Continents
Nov 03,2020: Coloplast acquires Nine Continents Medical
Nov 03,2020: Coloplast – Announcement no. 10/2020 – Full-year financial results 2019/20
Nov 03,2020: Coloplast delivers solid full year results despite the COVID-19 pandemic and expects 7-8% organic growth and 31-32% EBIT margin for 2020/21
Nov 03,2020: Coloplast – Announcement no. 11/2020 – Annual Report 2019/20 & Remuneration Report 2019/20

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Coloplast A/S – Key Facts
Coloplast A/S – Key Employees
Coloplast A/S – Key Employee Biographies
Coloplast A/S – Major Products and Services
Coloplast A/S – History
Coloplast A/S – Company Statement
Coloplast A/S – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Coloplast A/S – Business Description
Business Segment: Chronic Care
Overview
Performance
Business Segment: Interventional Urology
Overview
Performance
Business Segment: Wound & Skin Care
Overview
Performance
Geographical Segment: Emerging Markets
Performance
Geographical Segment: European Markets
Target Markets
Performance
Geographical Segment: Other Developed Markets
Target Markets
Performance
R&D Overview
Coloplast A/S – Corporate Strategy
Coloplast A/S – SWOT Analysis
SWOT Analysis – Overview
Coloplast A/S – Strengths
Coloplast A/S – Weaknesses
Coloplast A/S – Opportunities
Coloplast A/S – Threats
Coloplast A/S – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Coloplast A/S, Medical Equipment, Deals By Year, 2015 to YTD 2021
Coloplast A/S, Medical Equipment, Deals By Type, 2015 to YTD 2021
Coloplast A/S, Recent Deals Summary
Section 5 – Company’s Recent Developments
Nov 04, 2020: Coloplast acquires tibial nerve stimulation developer Nine Continents
Nov 03, 2020: Coloplast – Announcement no. 10/2020 – Full-year financial results 2019/20
Nov 03, 2020: Coloplast delivers solid full year results despite the COVID-19 pandemic and expects 7-8% organic growth and 31-32% EBIT margin for 2020/21
Nov 03, 2020: Coloplast – Announcement no. 11/2020 – Annual Report 2019/20 & Remuneration Report 2019/20
Sep 29, 2020: Coloplast launches new 2025 strategy and provides new long-term financial guidance
Aug 18, 2020: Coloplast reports -2% organic growth in Q3 due to significant negative impact from COVID-19 – and 5% year to date organic growth
Aug 18, 2020: Coloplast strengthens Executive Management
May 06, 2020: Coloplast: Interim Financial Report, H1 2019/20
May 06, 2020: Coloplast continues solid performance in Q2 with 9% organic growth
Feb 21, 2020: Coloplast – Announcement no. 2/2020 – share buyback programme
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Coloplast A/S, Key Facts
Coloplast A/S, Key Employees
Coloplast A/S, Key Employee Biographies
Coloplast A/S, Major Products and Services
Coloplast A/S, History
Coloplast A/S, Other Locations
Coloplast A/S, Subsidiaries
Coloplast A/S, Key Competitors
Coloplast A/S, Ratios based on current share price
Coloplast A/S, Annual Ratios
Coloplast A/S, Annual Ratios (Cont...1)
Coloplast A/S, Annual Ratios (Cont...2)
Coloplast A/S, Interim Ratios
Coloplast A/S, Medical Equipment, Deals By Year, 2015 to YTD 2021
Coloplast A/S, Medical Equipment, Deals By Type, 2015 to YTD 2021
Coloplast A/S, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Coloplast AS (COLO B):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Borregaard ASA (BRG):企業の財務・戦略的SWOT分析
    Borregaard ASA (BRG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Consumers Energy Co (CMS PR B):石油・ガス:M&Aディール及び事業提携情報
    Summary Consumers Energy Co (Consumers), formerly Consumers Power, is an electric and natural gas utility. The company generates purchases, transmits, distributes, and sells electricity. It also carries out the purchase, transmission, storage, distribution, and sale of natural gas. It generates elec …
  • The GPT Group (GPT):企業の財務・戦略的SWOT分析
    The GPT Group (GPT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Nuance Communications Inc (NUAN):企業の財務・戦略的SWOT分析
    Nuance Communications Inc (NUAN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Warner Music Group Corp.:企業の戦略的SWOT分析
    Warner Music Group Corp. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Luminus Devices Inc:電力:M&Aディール及び事業提携情報
    Summary Luminus Devices Inc (Luminus Devices), a subsidiary of Lightera Corp is a lighting product manufacturer that develops and manufactures solid state light sources for illumination applications. The company provides products such as COB arrays, mid power LEDs, high brightness, white LEDs, color …
  • Cebu Air Inc:戦略・SWOT・企業財務分析
    Cebu Air Inc - Strategy, SWOT and Corporate Finance Report Summary Cebu Air Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Emerald Health Therapeutics Inc (EMH):製薬・医療:M&Aディール及び事業提携情報
    Summary Emerald Health Therapeutics Inc (Emerald Health), formerly T-Bird Pharma Inc, is a producer of pharmaceutical grade medical cannabis. The company extracts and markets dried cannabis, and cannabis oils and capsules. It offers cannabinoid medicines, which are present in an unparalleled opportu …
  • Gabather AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Gabather AB (Gabather) is a developer of new drug candidates for the treatment of central nervous system diseases. The company spans its expertise in the development of anti-psychotics, anti-depressants and anxiolytics, analgesics, and cognition-enhancing treatments. It offers drug candidate …
  • Merit Medical Systems Inc (MMSI):企業の製品パイプライン分析
    Summary Merit Medical Systems Inc (Merit Medical) offers a range of single-use medical devices for interventional and diagnostic procedures. The company’s products include inflation devices and accessories, diagnostic and therapeutic catheters, diagnostic and hydrophilic products, thrombolytic cathe …
  • Globus Spirits Limited:企業の戦略・SWOT・財務情報
    Globus Spirits Limited - Strategy, SWOT and Corporate Finance Report Summary Globus Spirits Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • AVBOB Mutual Assurance Society:企業の戦略・SWOT・財務分析
    AVBOB Mutual Assurance Society - Strategy, SWOT and Corporate Finance Report Summary AVBOB Mutual Assurance Society - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • J. C. Penney Company, Inc.:企業の戦略・SWOT・財務情報
    J. C. Penney Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary J. C. Penney Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • General Electric Company:戦略・SWOT・企業財務分析
    General Electric Company - Strategy, SWOT and Corporate Finance Report Summary General Electric Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • BrightPath Biotherapeutics Co Ltd (4594):製薬・医療:M&Aディール及び事業提携情報
    Summary BrightPath Biotherapeutics Co Ltd (BrightPath Biotherapeutics), formerly GreenPeptide Co Ltd is a biopharmaceutical company that develops novel cancer immunotherapies. The company offers drug discovery research and early clinical development of cancer immunotherapy; early-phase clinical tria …
  • Joint Stock Commercial Bank for Foreign Trade of Vietnam (VCB):企業の財務・戦略的SWOT分析
    Joint Stock Commercial Bank for Foreign Trade of Vietnam (VCB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the c …
  • Plantronics, Inc. (PLT):企業の財務・戦略的SWOT分析
    Plantronics, Inc. (PLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • CP All Public Company Limited (CPALL):企業の財務・戦略的SWOT分析
    CP All Public Company Limited (CPALL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • TXU Energy Retail Company LLC:企業の戦略的SWOT分析
    TXU Energy Retail Company LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • AC Immune SA (ACIU):企業の財務・戦略的SWOT分析
    AC Immune SA (ACIU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆